There are 6 papers on CD4+CD28null T cells in aging research: 1 trial and 4 observational studies in people, 1 review.
6 papers study it3 more mention it9 findings
See all 9 papers on CD4+CD28null T cells
“At baseline, hyperuricemic patients had more CD4+CD28null/CD4+ cells than normouricemic subjects (36.8% vs. 6.1%; p = 0.001)”
- Human trial1
- Humans4
Interventions
1Allopurinol
downin humans1
1 study
Allopurinol
downin humans1
Allopurinol decreases CD4+CD28null T cells in humans (chronic hyperuricemia) (from 36.8% (23.0-43.7) to 15.8% (4.7-28.1)).
“CD4+CD28null cells decreased from 36.8% (23.0-43.7) to 15.8% (4.7-28.1; p = 0.031).”
Human trialchronic hyperuricemiaoralblood150 mg/day for 4 weeks, followed by 300 mg/day through week 1212 weeksn = 6
Clinical rheumatology
Upstream
2Coronary sinus vs vena cava
no changein humans1
1 study
Coronary sinus vs vena cava
no changein humans1
coronary sinus vs vena cava was not clearly linked with CD4+CD28null T cells in humans (coronary sinus vs vena cava in STEMI).
“no significant differences were detected in CD4+CD28null cells between coronary sinus and vena cava”
Humanscoronary sinus vs vena cava in STEMIbloodn = 24
Journal of vascular research
ST-elevation myocardial infarction
upin humans1
1 study
ST-elevation myocardial infarction
upin humans1
ST-elevation myocardial infarction is linked with higher CD4+CD28null T cells in humans (STEMI vs controls) (20.1 vs. 6.1%).
“alongside an increased proportion of CD4+ cells lacking CD28 expression (20.1 vs. 6.1%).”
HumansSTEMI vs controlsblood
Journal of vascular research
Associations
6Flow-mediated dilation
downin humans1
1 study
Flow-mediated dilation
downin humans1
CD4+CD28null T cells are associated with flow-mediated dilation in humans (R = -.422, p < .001).
“negative correlations were demonstrated between the FMD with CD4+CD57+ (R = -.236, p = .023), CD8+CD57+ (R = -.409, p < .001), CD4+CD28null (R = -.422, p < .001), and CD8+CD28null (R = -.318, p = .003).”
Humansfemales
International journal of rheumatic diseases
Carotid intima-media thickness
upin humans1
1 study
Carotid intima-media thickness
upin humans1
CD4+CD28null T cells are associated with carotid intima-media thickness in humans (R = .448, p < .001).
“Positive correlations were shown between cIMT with the CD4+CD57+ (R = .301, p = .005), CD4+CD28null (R = .448, p < .001), and CD8+CD28null (R = .422, p < .001).”
Humansfemales
International journal of rheumatic diseases
Hyperuricemia
upin humans1
1 study
Hyperuricemia
upin humans1
Hyperuricemia is associated with CD4+CD28null T cells in humans (normouricemic controls comparison at baseline) (36.8% vs. 6.1%).
“At baseline, hyperuricemic patients had more CD4+CD28null/CD4+ cells than normouricemic subjects (36.8% vs. 6.1%; p = 0.001)”
Human trialnormouricemic controls comparison at baselineblood
Clinical rheumatology
Vascular calcifications
upin humans1
1 study
Vascular calcifications
upin humans1
CD4+CD28null T cells are associated with vascular calcifications in chronic kidney disease.
“increases in CD4+CD28null were associated with overt vascular thickening and calcification.”
Humansin chronic kidney disease
Frontiers in medicine
Chronic kidney disease
upin humans1
1 study
Chronic kidney disease
upin humans1
Chronic kidney disease is associated with CD4+CD28null T cells in CKD stage 5 patients undergoing peritoneal dialysis (p < 0.001).
“Instead, CD4+CD28null frequency was increased (p < 0.001), especially in those with vascular calcifications.”
Humansin CKD stage 5 patients undergoing peritoneal dialysis
Frontiers in medicine
Early acute allograft rejection
downin humans1HR 0.65
1 study
Early acute allograft rejection
downin humans1HR 0.65
CD4+CD28null T cells are linked with a lower risk of early acute allograft rejection in humans (multivariate Cox regression analysis) (HR: 0.65, p = 0.028).
“higher CD4+CD28null T-cell numbers was associated with a lower risk for EAR (HR: 0.65, p = 0.028).”
Humansmultivariate Cox regression analysisn = 222
PloS one